Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry.
Francisco Javier Carrasco SánchezMª Dolores López-CarmonaFrancisco Javier Martínez-MarcosLuis M Pérez-BelmonteAlicia Hidalgo-JiménezVerónica BuonaiutoCarmen Suárez FernándezSantiago Jesús Freire CastroDavide LuordoPaula Maria Pesqueira FontanJulio César Blázquez EncinarJeffrey Oskar Magallanes GamboaAndrés de la Peña FernándezJosé David Torres PeñaJoaquim Fernández SolàJose Javier Napal LecumberriFrancisco Amorós MartínezMaría Esther Guisado EsparteroCarlos Jorge RipperRaquel Gómez MéndezNatalia Vicente LópezBerta Román BernalMaría Gloria Rojano RiveroJose-Manuel Ramos-RincónRicardo Gómez Huelgasnull nullPublished in: Annals of medicine (2020)
Admission hyperglycaemia is a strong predictor of all-cause mortality in non-critically hospitalized COVID-19 patients regardless of prior history of diabetes. KEY MESSAGE Admission hyperglycaemia is a stronger and independent risk factor for mortality in COVID-19. Screening for hyperglycaemia, in patients without diabetes, and early treatment of hyperglycaemia should be mandatory in the management of patients hospitalized with COVID-19. Admission hyperglycaemia should not be overlooked in all patients regardless prior history of diabetes.